MCID: CRD137
MIFTS: 46

Cardiogenic Shock malady

Categories: Rare diseases, Cardiovascular diseases

Aliases & Classifications for Cardiogenic Shock

Aliases & Descriptions for Cardiogenic Shock:

Name: Cardiogenic Shock 56
Shock, Cardiogenic 69
Shock Cardiogenic 52

Characteristics:

Orphanet epidemiological data:

56
cardiogenic shock
Prevalence: 1-5/10000 (Europe);

Classifications:



External Ids:

Orphanet 56 ORPHA97292
ICD10 via Orphanet 34 R57.0
ICD10 33 R57.0

Summaries for Cardiogenic Shock

MalaCards based summary : Cardiogenic Shock, also known as shock, cardiogenic, is related to myocardial infarction and hepatitis, and has symptoms including syncope and shock without mention of trauma. An important gene associated with Cardiogenic Shock is NPPB (Natriuretic Peptide B), and among its related pathways/superpathways are Folate Metabolism and Lung fibrosis. The drugs Heparin and Norepinephrine have been mentioned in the context of this disorder. Affiliated tissues include heart, liver and kidney, and related phenotype is cardiovascular system.

Wikipedia : 71 Cardiogenic shock is a life-threatening medical condition resulting from an inadequate circulation of... more...

Related Diseases for Cardiogenic Shock

Diseases related to Cardiogenic Shock via text searches within MalaCards or GeneCards Suite gene sharing:

(show top 50) (show all 278)
id Related Disease Score Top Affiliating Genes
1 myocardial infarction 31.2 CRP IL6 NPPB PIK3C2A PLAT TNF
2 hepatitis 29.9 IL6 TNF
3 aortic coarctation 29.6 IL6 TNF
4 lupus erythematosus 29.4 CRP IL6 PLAT
5 cardiac tamponade 11.3
6 n-terminal acetyltransferase deficiency 11.0
7 acute myocardial infarction 10.6
8 cardiomyopathy 10.4
9 citrulline transport defect 10.2 CRP NPPB
10 cardiac arrest 10.2
11 myocarditis 10.2
12 vitreous disease 10.2 NPPB PIK3C2A
13 cataract 10.2 CRP TNF
14 thrombosis 10.2
15 mechanical lagophthalmos 10.2 CRP TNF
16 central epithelioid sarcoma 10.2 CRP TNF
17 dermatomycosis 10.2 CRP TNF
18 scalp dermatosis 10.2 CRP TNF
19 generalized dystonia 10.2 CRP PIK3C2A
20 bile duct signet ring cell carcinoma 10.2 CRP TNF
21 glucosephosphate dehydrogenase deficiency 10.2 IL6 NPPB
22 hypertropia 10.2 CRP TNF
23 pyloric stenosis, infantile hypertrophic, 2 10.2 CRP TNF
24 coloboma of iris 10.2 CRP IL6
25 cutaneous sclerosis 10.2 CRP IL6
26 shoulder impingement syndrome 10.2 CRP IL6
27 neutrophilia, hereditary 10.1 CRP IL6
28 functional gastric disease 10.1 CRP TNF
29 cardiac tuberculosis 10.1 CRP IL6
30 cataract, total congenital 10.1 CRP IL6
31 laryngotracheoesophageal cleft type 2 10.1 CRP IL6
32 infiltrating ureter transitional cell carcinoma 10.1 PIK3C2A TNF
33 gastric lymphoma 10.1 CRP IL6
34 hemangioma of spleen 10.1 CRP IL6
35 mixed eosinophil-basophil adenoma 10.1 CRP IL6
36 retinal degeneration 10.1 CRP IL6
37 nodular nonsuppurative panniculitis 10.1 CRP IL6
38 vps11-related autosomal recessive hypomyelinating leukodystrophy 10.1 IL6 TNF
39 vitamin a embryopathy 10.1 IL6 PIK3C2A
40 multiple mitochondrial dysfunctions syndrome 10.1 CRP IL6
41 urticaria 10.1 CRP TNF
42 dyslexia 5 10.1 IL6 TNF
43 aortic atherosclerosis 10.1 IL6 TNF
44 esotropia 10.1 CRP IL6
45 degenerative disc disease 10.1 IL6 TNF
46 strawberry gallbladder 10.1 CRP TNF
47 pheochromocytoma 10.1
48 thymic neuroendocrine carcinoma 10.1 IL6 TNF
49 drug dependence 10.1 IL6 TNF
50 transient tic disorder 10.1 IL6 TNF

Comorbidity relations with Cardiogenic Shock via Phenotypic Disease Network (PDN): (show all 19)


Active Peptic Ulcer Disease Acute Cystitis
Acute Kidney Failure Cardiac Arrest
Chronic Kidney Failure Chronic Myocardial Ischemia
Deficiency Anemia Familial Atrial Fibrillation
Heart Disease Intermediate Coronary Syndrome
Ischemic Heart Disease Kidney Disease
Left Ventricular Outflow Tract Obstruction Mitral Valve Disease
Peripheral Vascular Disease Respiratory Failure
Third-Degree Atrioventricular Block Tricuspid Valve Disease
Ventricular Fibrillation, Familial, 1

Graphical network of the top 20 diseases related to Cardiogenic Shock:



Diseases related to Cardiogenic Shock

Symptoms & Phenotypes for Cardiogenic Shock

UMLS symptoms related to Cardiogenic Shock:


syncope, shock without mention of trauma

MGI Mouse Phenotypes related to Cardiogenic Shock:

44
id Description MGI Source Accession Score Top Affiliating Genes
1 cardiovascular system MP:0005385 9.02 CRP IL6 PIK3C2A PLAT TNF

Drugs & Therapeutics for Cardiogenic Shock

Drugs for Cardiogenic Shock (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show top 50) (show all 136)
id Name Status Phase Clinical Trials Cas Number PubChem Id
1
Heparin Approved, Investigational Phase 4,Phase 3,Phase 2 9005-49-6 772 46507594
2
Norepinephrine Approved Phase 4,Phase 3 51-41-2 439260
3
Epinephrine Approved, Vet_approved Phase 4,Phase 2 51-43-4 5816
4
Dexmedetomidine Approved, Vet_approved Phase 4 76631-46-4, 113775-47-6 68602 5311068 56032
5
Miconazole Approved, Investigational, Vet_approved Phase 4,Phase 2 22916-47-8 4189
6
Abciximab Approved Phase 4 143653-53-6
7
Lidocaine Approved, Vet_approved Phase 4 137-58-6 3676
8
Everolimus Approved Phase 4 159351-69-6 6442177
9
Ropivacaine Approved Phase 4 84057-95-4 71273 175805
10
Sirolimus Approved, Investigational Phase 4 53123-88-9 5284616 6436030 46835353
11
Tenecteplase Approved Phase 4,Phase 2,Phase 3 191588-94-0
12
Metoprolol Approved, Investigational Phase 4 37350-58-6, 51384-51-1 4171
13
Furosemide Approved, Vet_approved Phase 4,Phase 3 54-31-9 3440
14 Adrenergic Agents Phase 4,Phase 2,Phase 3
15 Simendan Phase 4,Phase 2,Phase 3
16 Adrenergic Agonists Phase 4,Phase 2,Phase 3
17 Adrenergic beta-Agonists Phase 4,Phase 2,Phase 3
18 Neurotransmitter Agents Phase 4,Phase 2,Phase 3
19 Peripheral Nervous System Agents Phase 4,Phase 2,Phase 3
20 Vasodilator Agents Phase 4,Phase 2,Phase 3
21 Anti-Arrhythmia Agents Phase 4,Phase 2,Phase 3
22 Phosphodiesterase Inhibitors Phase 4,Phase 2,Phase 3
23 Protective Agents Phase 4,Phase 2,Phase 3
24 Autonomic Agents Phase 4,Phase 2,Phase 3
25 calcium heparin Phase 4,Phase 3,Phase 2
26 Atorvastatin Calcium Phase 4 134523-03-8
27 Analgesics Phase 4
28 Mydriatics Phase 4,Phase 2
29 Adrenergic alpha-2 Receptor Agonists Phase 4
30 Adrenergic alpha-Agonists Phase 4,Phase 3,Phase 2
31 Tissue Plasminogen Activator Phase 4,Phase 3
32 Analgesics, Non-Narcotic Phase 4
33 Anesthetics Phase 4
34 Anesthetics, Local Phase 4
35 Vasoconstrictor Agents Phase 4,Phase 3,Phase 2
36 Epinephryl borate Phase 4,Phase 2
37 Hydroxymethylglutaryl-CoA Reductase Inhibitors Phase 4
38 Hypnotics and Sedatives Phase 4
39 Anti-Asthmatic Agents Phase 4,Phase 3,Phase 2
40 Anti-Bacterial Agents Phase 4
41 Hypolipidemic Agents Phase 4
42 Plasminogen Phase 4,Phase 3
43 Platelet Aggregation Inhibitors Phase 4,Phase 3,Phase 2
44 Immunoglobulin Fab Fragments Phase 4
45 Immunoglobulins Phase 4
46 Anti-Infective Agents Phase 4,Phase 2
47 Antibodies, Monoclonal Phase 4
48 Immunosuppressive Agents Phase 4,Phase 2
49 Fibrinolytic Agents Phase 4,Phase 3,Phase 2
50 Anticholesteremic Agents Phase 4

Interventional clinical trials:

(show top 50) (show all 103)
id Name Status NCT ID Phase
1 Abciximab in Patients Undergoing Percutaneous Coronary Intervention for Cardiogenic Shock Completed NCT00420030 Phase 4
2 Intraaortic Balloon Pump in Cardiogenic Shock II Completed NCT00491036 Phase 4
3 Efficacy Study of LV Assist Device to Treat Patients With Cardiogenic Shock (ISAR-SHOCK) Completed NCT00417378 Phase 4
4 Study Comparing the Efficacy and Tolerability of Epinephrine and Norepinephrine in Cardiogenic Shock Completed NCT01367743 Phase 4
5 Levosimendan in Acute Heart Failure Following Acute Myocardial Infarction. Completed NCT00324766 Phase 4
6 Acute Chest Pain Treatment and Evaluation (ACTION) Study Completed NCT00434564 Phase 4
7 Addition of Dexmedetomidine to Ropivacaine-induced Supraclavicular Block (ADRIB Trial) Completed NCT02630290 Phase 4
8 Safety and Efficacy Study Comparing 3 New Types of Coronary Stents Completed NCT01166685 Phase 4
9 To Investigate the Role of Upstream High Dose Statin in STEMI Completed NCT01050348 Phase 4
10 Providing Rapid Out of Hospital Acute Cardiovascular Treatment (PROACT) Completed NCT01634425 Phase 4
11 Clinical Study of Extra-Corporal Life Support in Cardiogenic Shock Complicating Acute Myocardial Infarction Recruiting NCT02544594 Phase 4
12 ExtraCorporeal Membrane Oxygenation in the Therapy of Cardiogenic Shock Recruiting NCT02301819 Phase 4
13 Culprit Lesion Only PCI Versus Multivessel PCI in Cardiogenic Shock Recruiting NCT01927549 Phase 4
14 Effect of METOprolol in CARDioproteCtioN During an Acute Myocardial InfarCtion. The METOCARD-CNIC Trial. Active, not recruiting NCT01311700 Phase 4
15 Diuretic Vascular Filling in the Initial Management of Acute PE With Right Ventricular Dysfunction Normotensive Not yet recruiting NCT02531581 Phase 4
16 Comparison of Standard Treatment Versus Standard Treatment Plus Extracorporeal Life Support (ECLS) in Myocardial Infarction Complicated With Cardiogenic Shock Terminated NCT00314847 Phase 4
17 A Trial Evaluating the Efficacy and Safety of Tenecteplase Together With Unfractionated Heparin Prior to Early Percutaneous Coronary Intervention (PCI) as Compared to Standard Primary PCI in Patients With Acute Myocardial Infarction (ASSENT 4 PCI) Terminated NCT00168792 Phase 4
18 Levosimendan Versus Dobutamine in Shock Patients Unknown status NCT00093301 Phase 2, Phase 3
19 Adjunctive Mild Hypothermia Therapy to Primary Percutaneous Coronary Intervention in Patients With Acute Myocardial Infarction Complicated With Shock: A Feasibility Study Unknown status NCT00846222 Phase 3
20 Liberal Versus Restrictive Use of Dobutamine in Cardiac Surgery Unknown status NCT02361801 Phase 3
21 Impact of Different Treatment in Multivessel Non ST Elevation Myocardial Infarction (NSTEMI) Patients: One Stage Versus Multistaged Percutaneous Coronary Intervention (PCI) Unknown status NCT01478984 Phase 3
22 Best Bypass Surgery (BBS) Trial Unknown status NCT00120991 Phase 3
23 Shock Trial: Should We Emergently Revascularize Occluded Coronaries for Cardiogenic Shock. Completed NCT00000552 Phase 3
24 Safety and Efficacy Study of Eptifibatide in Primary Percutaneous Coronary Intervention (PCI) Completed NCT00251823 Phase 3
25 The STREAM Percutaneous Coronary Intervention Anticoagulant Sub-study Completed NCT00882635 Phase 3
26 Dopamine and Norepinephrine in Shock Patients Completed NCT00314704 Phase 3
27 Which Therapy for Acute Heart Attacks? (The WEST Study) Completed NCT00121446 Phase 2, Phase 3
28 STREAM-Strategic Reperfusion (With Tenecteplase and Antithrombotic Treatment) Early After Myocardial Infarction Completed NCT00623623 Phase 3
29 REsearching Coronary REduction by Appropriately Targeting Euglycemia (RECREATE Pilot Study) Completed NCT00640991 Phase 3
30 Danish Cardiogenic Shock Trial Recruiting NCT01633502 Phase 3
31 Anti-inflammatory Effect of Therapeutic Hypothermia in Acute Myocardial Infarction Complicated With Cardiogenic Shock Recruiting NCT02633358 Phase 2, Phase 3
32 Impact of Perioperative Exenatide Infusion on Quality of Life in Cardiac Surgery Patients Recruiting NCT02432976 Phase 2, Phase 3
33 Effect of External Counter Pulsation on Ischemic Stroke Not yet recruiting NCT03075137 Phase 3
34 Bromocriptine in the Treatment of Peripartum Cardiomyopathy Not yet recruiting NCT02590601 Phase 3
35 Efficacy of Furosemide Versus Vascular Filling in Patients With Acute Myocardial Infarction Not yet recruiting NCT02905760 Phase 3
36 A Study of the Safety and Efficacy of Nitric Oxide Reduction in Patients With Cardiogenic Shock After a Heart Attack Terminated NCT00112281 Phase 3
37 Clot Dissolving Treatment for Blood Clots in the Lungs Terminated NCT00680628 Phase 3
38 Reducing Elevated Heart Rate in Patients With Multiple Organ Dysfunction Syndrome (MODS) by Ivabradine Unknown status NCT01186783 Phase 2
39 Effects of Pyruvate in Patients With Cardiogenic Shock and Intra-aortic Balloon Counterpulsation Completed NCT00604331 Phase 2
40 Study of Multistep Pharmacological and Invasive Management for Cardiogenic Shock Recruiting NCT02591771 Phase 2
41 Esmolol Infusion for Patients With Septic Shock and Persistent Tachycardia Recruiting NCT02841241 Phase 2
42 Exenatide for Myocardial Protection During Reperfusion Study Recruiting NCT01938235 Phase 2
43 HEROIC (Heparin Requirement in Counterpulsation) Terminated NCT00445211 Phase 2
44 The Melatonin Adjunct in the Acute myocaRdial Infarction Treated With Angioplasty Terminated NCT00640094 Phase 2
45 Catheter Thrombectomy in Patients With Massive Pulmonary Embolism Terminated NCT00314002 Phase 1, Phase 2
46 The Effects of Nitric Oxide for Inhalation in Right Ventricular Infarction Patients Terminated NCT00782652 Phase 2
47 Cyclosporine in Acute Myocardial Infarction Complicated by Cardiogenic Shock Withdrawn NCT01901471 Phase 2
48 Therapeutic Hypothermia for Severe Acute Pancreatitis Withdrawn NCT01794858 Phase 2
49 The Effect of Remote Ischemic Preconditioning in the Cardiac Surgery Completed NCT00997217 Phase 1
50 Oxidant-antioxidant Activity, Free Radicle Activity, Immune Response and Biomarkers in Extracorporeal Membrane Oxygenation (ECMO) Patients Unknown status NCT01089036

Search NIH Clinical Center for Cardiogenic Shock

Inferred drug relations via UMLS 69 / NDF-RT 48 :


Genetic Tests for Cardiogenic Shock

Anatomical Context for Cardiogenic Shock

MalaCards organs/tissues related to Cardiogenic Shock:

39
Heart, Liver, Kidney, Monocytes, Tongue, Pituitary, Endothelial

Publications for Cardiogenic Shock

Articles related to Cardiogenic Shock:

(show top 50) (show all 671)
id Title Authors Year
1
Levosimendan as a treatment for acute renal failure associated with cardiogenic shock after hip fracture. ( 28017176 )
2017
2
Transvenous Inoue balloon aortic valvuloplasty with intra-aortic balloon pump in treating cardiogenic shock due to critical calcific aortic stenosis. ( 28044253 )
2017
3
Moving Beyond SHOCK: New Paradigms in the Management of Acute Myocardial Infarction Complicated by Cardiogenic Shock. ( 28024554 )
2017
4
Bridge to transplant or recovery in cardiogenic shock in a developing country. ( 28084085 )
2017
5
Adrenomedullin: a marker of impaired hemodynamics, organ dysfunction, and poor prognosis in cardiogenic shock. ( 28050899 )
2017
6
The prognostic value of MR-proadrenomedullin in patients with acute coronary syndrome complicated by cardiogenic shock. ( 27788594 )
2017
7
Prognostic Value of Relative Adrenal Insufficiency During Cardiogenic Shock: A Prospective Cohort Study With Long-Term Follow-Up. ( 27984534 )
2017
8
Use of noninvasive and invasive mechanical ventilation in cardiogenic shock: A prospective multicenter study. ( 28043661 )
2017
9
Percutaneous Veno-Arterial Extracorporeal Membrane Oxygenation for Refractory Cardiogenic Shock is Associated with Improved Short and Long Term Survival. ( 27045967 )
2016
10
Cardiogenic Shock: Failure of Oxygen Delivery and Oxygen Utilization. ( 27509355 )
2016
11
Bilateral Giant Coronary Artery Aneurysms Complicated by Acute Coronary Syndrome and Cardiogenic Shock. ( 27000621 )
2016
12
Right-left ventricular interdependence: a promising predictor of successful extracorporeal membrane oxygenation (ECMO) weaning after assistance for refractory cardiogenic shock. ( 28011989 )
2016
13
Spontaneous, Postpartum Coronary Artery Dissection and Cardiogenic Shock with Extracorporeal Membrane Oxygenation Assisted Recovery in a 30-Year-Old Patient. ( 27127660 )
2016
14
Shock Index More Sensitive Than Cardiogenic Shock in ST-Elevation Myocardial Infarction Treated by Primary Percutaneous Coronary Intervention. ( 27980279 )
2016
15
Salvage myocardial revascularisation in spontaneous left main coronary artery dissection with cardiogenic shock - the role of mechanical circulatory support. ( 27625335 )
2016
16
Clinical outcomes of drug-eluting stents versus bare-metal stents in patients with cardiogenic shock complicating acute myocardial infarction. ( 27111168 )
2016
17
Survival, quality of life and impact of right heart failure in patients with acute cardiogenic shock treated with ECMO. ( 27515989 )
2016
18
TCT-145 Rheolytic Thrombectomy for Acute Myocardial Infarction Complicated by Cardiogenic Shock. ( 27970309 )
2016
19
Cardiogenic shock complicating ST-elevation myocardial infarction: a very difficult clinical scenario. ( 27028593 )
2016
20
Use of the Impella Device for Acute Coronary Syndrome Complicated by Cardiogenic Shock - Experience From a Single Heart Center With Analysis of Long-term Mortality. ( 27529657 )
2016
21
Predictors of in-hospital mortality among cardiogenic shock patients. Prognostic and therapeutic implications. ( 27648979 )
2016
22
Bridge to durable left ventricular assist device for refractory cardiogenic shock. ( 27988030 )
2016
23
Impact of atrial pacing on cardiogenic shock due to the deterioration of tricuspid regurgitation. ( 27544598 )
2016
24
Refractory pediatric cardiogenic shock: A case for mechanical support. ( 27994387 )
2016
25
Cardiogenic Shock due to Psychosis-Induced Inverted Takotsubo Cardiomyopathy Bridged-to-Recovery with a Percutaneous Left Ventricular Assist Device. ( 28058119 )
2016
26
Resolution of Cardiogenic Shock Using Echocardiography-Guided Pacing Optimization in Intensive Care: A Case Series. ( 27007670 )
2016
27
Effects of Additional Intra-aortic Balloon Counter-Pulsation Therapy to Cardiogenic Shock Patients Supported by Extra-corporeal Membranous Oxygenation. ( 27032984 )
2016
28
Follow-up Electrocardiograms in a Patient With Incarcerated Bowel-Triggered Takotsubo Syndrome Complicated by Cardiogenic Shock. ( 27998688 )
2016
29
TCT-22 Dual Mechanical Support Combining Impella Microaxial Pump and Veno-arterial ECMO Rescues High-risk Patients in Refractory Cardiogenic Shock. ( 27970394 )
2016
30
Total revascularization for an epsilon right coronary artery and severe left main disease combined with profound cardiogenic shock: A case report. ( 27977615 )
2016
31
Limited evidence of improved efficacy regarding drug eluting stents in patients with cardiogenic shock. ( 27532231 )
2016
32
Effect of Early Initiation of Mechanical Circulatory Support on Survival in Cardiogenic Shock. ( 28040188 )
2016
33
Dilated cardiomyopathy with cardiogenic shock in a child with Kearns-Sayre syndrome. ( 26884075 )
2016
34
Cardiogenic Shock From Coronary Compression: A Difficult Diagnosis But Easy Fix. ( 27000612 )
2016
35
Percutaneous Ventricular Assist Devices: A Novel Approach in the Management of Patients With Acute Cardiogenic Shock. ( 27660572 )
2016
36
Impact of Pulmonary Artery Catheter Use on Short- and Long-Term Mortality in Patients with Cardiogenic Shock. ( 27553044 )
2016
37
Cardiogenic Shock Following Amplatzer Device Embolization Due to Left Ventricular Outflow Tract Obstruction. ( 26748636 )
2016
38
Peroxiredoxin 1 induces inflammatory cytokine response and predicts outcome of cardiogenic shock patients necessitating extracorporeal membrane oxygenation: an observational cohort study and translational approach. ( 27142532 )
2016
39
Associations with 30-day survival following extracorporeal membrane oxygenation in patients with acute ST segment elevation myocardial infarction and profound cardiogenic shock. ( 27601212 )
2016
40
Short-term and long-term prognostic outcomes of patients with ST-segment elevation myocardial infarction complicated by profound cardiogenic shock undergoing early extracorporeal membrane oxygenator-assisted primary percutaneous coronary intervention. ( 27544596 )
2016
41
Post-partum hemorrhage complicated by reverse-Takotsubo cardiogenic shock; a novel therapeutic approach. ( 28012808 )
2016
42
Intra-aortic balloon pump combined with mechanical ventilation for treating patients ageda88>a8860 years in cardiogenic shock: Retrospective analysis. ( 27020597 )
2016
43
How should I treat a massive left main coronary artery thrombosis in a 49-year-old woman in the context of cardiogenic shock? ( 27056129 )
2016
44
Extracorporeal life support during cardiac arrest and cardiogenic shock: a systematic review and meta-analysis. ( 27647331 )
2016
45
An unusual case of cardiogenic shock in which thiamine administration led to reversal of lactic acidosis and heart function recovery: Shoshin beriberi in an adolescent. ( 27505323 )
2016
46
Impact of immediate multivessel percutaneous coronary intervention versus culprit lesion intervention on 1-year outcome in patients with acute myocardial infarction complicated by cardiogenic shock: Results of the randomised IABP-SHOCK II trial. ( 27655918 )
2016
47
Biventricular Circulatory Support Using 2 Axial Flow Catheters for Cardiogenic Shock Without the Need for Surgical Vascular Access. ( 27188188 )
2016
48
Short-term ventricular assist device as a bridge to decision in cardiogenic shock: is it a justified strategy? ( 27184945 )
2016
49
Bilateral pleural effusion, cardiogenic shock, renal failure, and generalized anasarca: A dreaded iatrogenic complication of umbilical venous catheterization. ( 27011707 )
2016
50
"Smoker's paradox" in patients with cardiogenic shock complicating myocardial infarction - A substudy of the IABP-SHOCK II-trial and registry. ( 27521557 )
2016

Variations for Cardiogenic Shock

Expression for Cardiogenic Shock

Search GEO for disease gene expression data for Cardiogenic Shock.

Pathways for Cardiogenic Shock

GO Terms for Cardiogenic Shock

Cellular components related to Cardiogenic Shock according to GeneCards Suite gene sharing:

id Name GO ID Score Top Affiliating Genes
1 extracellular region GO:0005576 9.35 CRP IL6 NPPB PLAT TNF
2 extracellular space GO:0005615 9.02 CRP IL6 NPPB PLAT TNF

Biological processes related to Cardiogenic Shock according to GeneCards Suite gene sharing:

(show all 13)
id Name GO ID Score Top Affiliating Genes
1 inflammatory response GO:0006954 9.67 CRP IL6 TNF
2 positive regulation of gene expression GO:0010628 9.65 CRP IL6 TNF
3 positive regulation of smooth muscle cell proliferation GO:0048661 9.52 IL6 TNF
4 humoral immune response GO:0006959 9.51 IL6 TNF
5 negative regulation of fat cell differentiation GO:0045599 9.46 IL6 TNF
6 positive regulation of interleukin-6 production GO:0032755 9.43 IL6 TNF
7 positive regulation of nitric oxide biosynthetic process GO:0045429 9.4 IL6 TNF
8 acute-phase response GO:0006953 9.37 CRP IL6
9 platelet-derived growth factor receptor signaling pathway GO:0048008 9.32 PIK3C2A PLAT
10 positive regulation of chemokine production GO:0032722 9.26 IL6 TNF
11 epithelial cell proliferation involved in salivary gland morphogenesis GO:0060664 9.16 IL6 TNF
12 defense response to Gram-positive bacterium GO:0050830 9.13 CRP IL6 TNF
13 negative regulation of lipid storage GO:0010888 8.8 CRP IL6 TNF

Molecular functions related to Cardiogenic Shock according to GeneCards Suite gene sharing:

id Name GO ID Score Top Affiliating Genes
1 receptor binding GO:0005102 8.8 IL6 NPPB PLAT

Sources for Cardiogenic Shock

3 CDC
7 CNVD
9 Cosmic
10 dbSNP
11 DGIdb
16 ExPASy
18 FMA
28 GO
29 GTR
30 HGMD
31 HMDB
32 HPO
33 ICD10
34 ICD10 via Orphanet
35 ICD9CM
36 IUPHAR
37 KEGG
38 LifeMap
40 MedGen
42 MeSH
43 MESH via Orphanet
44 MGI
46 NCI
47 NCIt
48 NDF-RT
51 NINDS
52 Novoseek
54 OMIM
55 OMIM via Orphanet
59 PubMed
60 QIAGEN
65 SNOMED-CT via Orphanet
67 TGDB
68 Tocris
69 UMLS
70 UMLS via Orphanet
Content
Loading form....